CoChat

Bacteriological Outcome after Valve Surgery for Active Infective Endocarditis: Implications for Duration of Treatment after Surgery

The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.

Abstract

BACKGROUND: There has been no systematic evaluation of outcome after surgery for infective endocarditis with respect to duration of antibiotic treatment. METHODS: We performed a retrospective chart review of episodes of valve surgery for active infective endocarditis at Green Lane Hospital (Auckland, New Zealand) for 1963-1999. We recorded the duration of antibiotic treatment before and after valve surgery; the extent of infection at operation; Gram stain, culture, and histopathological testing results for valve samples; and the bacteriological outcome after surgery. The primary outcome measure was relapse, defined as endocarditis due to the same species within 1 year after surgery. RESULTS: For the 358 patients in our study, the median duration of follow-up was 4.8 years. Thirty-two patients (9%) had 36 subsequent episodes of endocarditis. Relapse occurred after 3 (0.8%) of the operations (95% CI, 0.2%-2.0%). Relapse of infection was unrelated to the duration of antibiotic treatment before or after surgery, positive valve culture results, positive Gram stain results, or perivalvular infection. Since 1994, we have reduced the duration of antibiotic treatment by approximately 7 days for those with positive valve culture results and by approximately 14 days for those with negative valve culture results, without any increase in the number of relapses. CONCLUSIONS: Relapse is an uncommon event following surgery for endocarditis. Commonly suggested indications for prolonging postoperative treatment are not associated with higher relapse rates, and their relevance is debatable. We conclude that it is unnecessary to continue treatment for patients with negative valve culture results for an arbitrary 4-6-week period after surgery. Two weeks of treatment appears to be sufficient, and, for those operated on near the end of the standard period of treatment, simply completing the planned course should suffice.

Overview

Integrity signals

Registry

Crossref · 10.1086/430908

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 79 references

Research works printed but not linked: 14

  1. Wells AU, 1990, New Zealand. Q J Med, 76, 753
  2. Peat EB, 1989, N Z Med J, 102, 33
  3. Kay PH, 1984, J Cardiovasc Surg (Torino), 25, 321
  4. Wilson W, 1979, Mayo Clin Proc, 54, 223
  5. Vlessis AA, 1997, J Heart Valve Dis, 6, 443
  6. Gulbins H, 2002, J Heart Valve Dis, 11, 492
  7. Aranki SF, 1994, Circulation, 90, I175
  8. Cotrufo M, 2001, J Heart Valve Dis, 10, 478
  9. Petrou M, 1994, Circulation, 90, I198
  10. Larbalestier RI, 1992, Circulation, 86, I68
  11. McKay G, 2002, N Z Med J, 115, 124
  12. Grandmougin D, 1999, J Heart Valve Dis, 8, 234
  13. Pansini S, 1997, J Heart Valve Dis, 6, 84
  14. Truninger K, 1999, Heart, 82, 714, 10.1136/hrt.82.6.714 · DOI · Paper page

Cited by

Metadata

Authors
Morris, A. J., Drinković, D., Pottumarthy, S., MacCulloch, D., Kerr, A. R., & West, T.
Affiliations
Greenlane Clinical Centre (NZ)
Corresponding author
Morris, Arthur J.
Venue
Clinical Infectious Diseases
Published
2005-07-15
Volume
41
Issue
2
Pages
187-194
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2130095935
Cited by
79
References
79
Citations by year
2026: 4 · 2025: 8 · 2024: 3 · 2023: 5 · 2022: 4 · 2021: 4 · 2020: 8 · 2019: 4 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 2 · 2014: 1 · 2013: 5 · 2012: 4
FWCI
2.15
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
  • Health Sciences › Medicine › Surgery › Orthopedic Infections and Treatments
Keywords
infective endocarditis, valve surgery, Gram staining, heart valve infection
MeSH terms
Aged, Anti-Bacterial Agents, Drug Administration Schedule, Endocarditis, Bacterial, Female, Heart Valve Diseases, Heart Valves, Humans, Male, Middle Aged, Recurrence, Retrospective Studies, Time Factors, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.